AstraZeneca Offers $10 Billion for Rhythm Pharmaceuticals

• AstraZeneca made a $10 billion offer for Rhythm Pharmaceuticals.
• The offer was reported by Reuters and The Wall Street Journal.
• Rhythm Pharmaceuticals specializes in obesity treatments.
• The deal is currently under consideration.
• No further details on the offer's acceptance are available.